A Clinical Evaluation of Efficacy of Ayurvedic treatment regimen as an Add-on therapy with Modern Medicine in COVID 19 - A Randomized, Multi-center, Single Blind, Prospective Clinical Study

Ministry of AYUSH0 个研究点目标入组 390 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. All hospitalized cases above 18 years of age, clinically diagnosed with corona virus disease 2019 and presenting with mild to moderate signs and symptoms of COVID-19, quarantined at identified hospital set up.
•2. Participants who can take medicines orally.
•3. Patients willing to provide signed informed consent.

•1. Cases of severe vomiting which would affect oral administration of medicine difficult.
•2. Cases of respiratory failure and requiring mechanical ventilation.
•3. Combined organ failure requiring ICU monitoring.
•4. Pregnant and lactating women.
•5. Subjects having an active malignancy.
•6. Subjects giving history of significant cardiovascular event < 12 weeks prior to randomization.
•7. Subjects having a chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
•8. Subjects having active metabolic or gastrointestinal diseases that may interfere with nutrient absorption, metabolism, or excretion, excluding diabetes.
•9. Any other condition, which as per the investigator would jeopardize the outcome of the trial.

发起方